Pozelimab, CAS 2096328-94-6

Product Description: Pozelimab (REGN3918) is a fully human IgG4 anti-C5 monoclonal antibody. Pozelimab binds to C5 and C5 variants with high affinity and blocks complement-mediated hemolysis. Pozelimab can be used for the research of complement-mediated diseases[1].

Applications: Metabolism-protein/nucleotide metabolism

Formula: N/A

References: [1]Latuszek A, et al. Inhibition of complement pathway activation with Pozelimab, a fully human antibody to complement component C5. PLoS One. 2020 May 8;15(5):e0231892.

CAS Number: 2096328-94-6

Molecular Weight: N/A

Compound Purity: 99.45

Research Area: Metabolic Disease

Solubility: 10 mM in DMSO

Target: Complement System

• Artikelnummer: MEXHY-P99786-5
• Hersteller: MedChemExpress
• Hersteller Artikelnummer: HY-P99786-5
• Verpackungseinheit: 5 mg
• Mengeneinheit: STK
• Konjugat: Unconjugated